SMTL ID : 7nee.1

Inhibitor Complex with Thrombin Activatable Fibrinolysis inhibitor (TAFIa)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

monomer

Ligands

1 x U9B: (1R,3S)-3-(4-ammoniobutyl)-1-benzyl-1,4-azaphosphinan-1-ium-3-carboxylate 4,4-dioxide(Non-covalent)

U9B.1: 23 residues within 4Å: Chain A: V.34, H.158, E.161, R.216, N.233, R.234, H.287, S.288, Y.289, S.290, V.294, S.298, G.335, S.336, T.338, Y.340, L.341, A.342, G.345, D.347, T.360, E.362 Ligands: ZN.2 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:T.338, A:Y.340 Hydrogen bonds: A:H.158, A:R.216, A:R.216, A:N.233, A:H.287, A:T.360, A:T.360 Salt bridges: A:H.158, A:R.216, A:R.234, A:E.362

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 5 residues within 4Å: Chain A: H.158, E.161, H.287, S.288 Ligands: U9B.1 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.158, A:E.161, A:E.161, A:H.287

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schaffner, A.P. et al., Phosphinanes and Azaphosphinanes as Potent and Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa). J.Med.Chem. (2021)

Release Date

2021-04-07

Peptides

Carboxypeptidase B2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carboxypeptidase B2